GeneThera is a biotechnology company that specializes in developing diagnostic tests and vaccines for zoonotic diseases. These are diseases that originate in animals and are capable of causing infectious diseases in humans. More than 80% of all human infectious disease are caused by zoonotic viruses... GeneThera is a biotechnology company that specializes in developing diagnostic tests and vaccines for zoonotic diseases. These are diseases that originate in animals and are capable of causing infectious diseases in humans. More than 80% of all human infectious disease are caused by zoonotic viruses and bacteria. Examples of infectious agents transmitted from animals to humans are, SARS-Cov-2, E.Coli, Mad Cow disease, and Mycobacterium Avium Sub. Paratuberculosis. GeneThera's technology and business model are dedicated to developing the infrastructure of a global network that operates as a Zoonotic Infectious Disease Alert Shield (ZIDAS) to control and prevent pandemics from developing. Genethera's model is based on an Ultrahigh Throughput Molecular Robotic/AI Platform (MORAP) that combines the use of advanced robotic integrated systems with Artificial Intelligence (AI). This technology platform can process millions of samples, collecting, storing, and analyzing data. Genethera has designed a 2nd generation robotic prototype. The system is capable of processing over 100,000 samples/daily with minimum human intervention. 더 보기
Applied Genetics Initiates Commercial Operation PR Newswire WESTMINSTER, Colo., June 25, 2012 WESTMINSTER, Colo., June 25, 2012 /PRNewswire/ -- GeneThera Inc. (OTCQB: GTHR) is pleased to announce...
Applied Genetics Signs Agreement With The National University Of Mexico (UNAM) PR Newswire WESTMINSTER, Colo., May 16, 2012 WESTMINSTER, Colo., May 16, 2012 /PRNewswire/ -- GeneThera, Inc...
Applied Genetics Signs Marketing and Sales Agreement with Nutricion Avanzada PR Newswire WESTMINSTER, Colo., Feb. 22, 2012 WESTMINSTER, Colo., Feb. 22, 2012 /PRNewswire/ -- GeneThera Inc...
GeneThera, Inc. Acquires Applied Genetics, S.A. PR Newswire WESTMINSTER, Colo., Jan. 25, 2012 WESTMINSTER, Colo., Jan. 25, 2012 /PRNewswire/ -- GeneThera, Inc. (OTCQB: GTHR) announced today...
Results from Pharma Finance 2009 ARVADA, Colo., June 16 /PRNewswire-FirstCall/ -- GeneThera, Inc. (OTC: GTHR.PK). GeneThera, as a service and responsibility to our shareholders, is addressing...
NEW YORK, Nov. 25 /PRNewswire-FirstCall/ -- Wall St. Network's 3-Minute Press Show is a daily program hosted by WSN reporter Tracee Tolentino that features in-depth interviews with public...
WHEAT RIDGE, Colo., Nov. 24 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR.PK), announces it will soon begin offering its Real Time PCR test for Johne's disease through its Wheat...
WHEAT RIDGE, Colo., Nov. 17 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR), today released information about its E.Coli O157:H7 vaccine. The vaccine consists of Live Attenuated...
NEW YORK, Nov. 4 /PRNewswire-FirstCall/ -- Wall St. Network's 3-Minute Press Show is a daily program hosted by WSN reporter Tracee Tolentino that features in-depth interviews with public company...
WHEAT RIDGE, Colo., Nov. 3 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR), As a service and responsibility to our shareholders, GeneThera is publicly outlining our strategy for...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 0 | 0 | CS |
26 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 8242 | 0.0001 | CS |
52 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 6681 | 9.259E-5 | CS |
156 | -0.0447 | -99.7767857143 | 0.0448 | 0.068 | 1.0E-6 | 17795 | 0.02567782 | CS |
260 | -0.0069 | -98.5714285714 | 0.007 | 0.47 | 1.0E-6 | 79904 | 0.05688978 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관